IL2 and neoplasm: In contrast in KIRC with lower response to high-dose IL-2 and lower PD-L1 mRNA expression, the weak immune response may attribute to the lack of tumor-specific antigens on tumor cells and the secretion of immunosuppressive cytokines such as VEGF and TGF-β [22].